AXSM · Axsome Therapeutics, Inc. · Documents
$145.04
-11.03 (-7.07%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$7.60B
Shares
52.38M
Volume · Oct 23
1.59M
Avg daily vol (3M)
738.87K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2020-12-31 | — | |
| 8-K | — | 2020-12-08 | — | |
| 8-K | — | 2020-12-02 | — | |
| 8-K | — | 2020-12-01 | — | |
| 10-Q/A | — | 2020-11-06 | 2020-09-30 | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-11-05 | — | |
| 8-K | — | 2020-09-29 | 2020-09-25 | |
| 8-K | — | 2020-09-24 | — | |
| 8-K/A | — | 2020-09-22 | 2020-09-21 | |
| 8-K | — | 2020-09-21 | — | |
| 8-K | — | 2020-09-16 | 2020-09-14 | |
| 8-K | — | 2020-09-14 | — | |
| 8-K | — | 2020-09-08 | 2020-09-03 | |
| 8-K | — | 2020-08-31 | — | |
| 8-K | — | 2020-08-20 | — | |
| 8-K | — | 2020-08-10 | — | |
| 10-Q | — | 2020-08-10 | 2020-06-30 | |
| 8-K | — | 2020-08-05 | — | |
| 8-K | — | 2020-07-13 | — | |
| 8-K | — | 2020-06-26 | — | |
| 8-K | — | 2020-06-08 | 2020-06-05 | |
| 10-Q | — | 2020-05-11 | 2020-03-31 | |
| 8-K | — | 2020-05-08 | — | |
| 8-K | — | 2020-04-27 | — | |
| 8-K | — | 2020-04-21 | 2020-04-19 | |
| DEF 14A | — | 2020-04-21 | 2020-06-05 | |
| 8-K | — | 2020-04-06 | — | |
| 8-K | — | 2020-03-30 | — | |
| 8-K | — | 2020-03-20 | — | |
| 8-K | — | 2020-03-12 | — | |
| 8-K | — | 2020-03-12 | — | |
| 10-K | — | 2020-03-12 | 2019-12-31 | |
| 8-K | — | 2020-03-05 | 2020-02-28 | |
| 8-K | — | 2020-02-20 | — | |
| 8-K | — | 2020-01-22 | — | |
| 8-K | — | 2020-01-13 | 2020-01-10 |
Showing 151–187 of 187 filings
Key facts
CIK
1579428
CUSIP
05464T104
13F (30d)
67 filings
63 filers
Visit website
Investor relations